New weightloss treatment becomes first FDAapproved drug for sleep apnea
Dec 20, 2024
The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder.
https://www.staradvertiser.com/2024/12/20/breaking-news/new-weight-loss-treatment-becomes-first-fda-approved-drug-for-sleep-apnea/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service